Tech

FibroBiologics Inc, the clinical-stage biotechnology company pioneering therapeutics for chronic diseases through fibroblasts and fibroblast-derived materials, witnessed a tumultuous debut on the Nasdaq stock exchange.

Following the implementation of CareMax Inc.’s 1-for-30 reverse stock split on January 31, 2024, the market response has been far from what the company might

In a strategic move to reshape its financial landscape, Volcon Inc the pioneering all-electric off-road powersports company, has taken a bold step by announcing a